Institution
American Cancer Society
Nonprofit•Atlanta, Georgia, United States•
About: American Cancer Society is a nonprofit organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Cancer & Population. The organization has 1339 authors who have published 3700 publications receiving 688166 citations. The organization is also known as: American Cancer Society, ACS & American Society for the Control of Cancer.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The results suggest that certain senescence‐like phenotypes may not reflect a terminal state of growth arrest, as cells that recover with self‐renewal capacity may ultimately contribute to disease recurrence.
101 citations
••
TL;DR: ACS NSQIP has not only demonstrated how and why the use of accurate clinical data is crucial, but also how the program, through its risk-adjusted feedback, improvement tools, and hospital collaboratives, helps hospitals and providers to achieve safer surgery and better patient care.
101 citations
••
01 Oct 2011TL;DR: This first study of sentiment benefits and dynamics in a large-scale health-related electronic community finds that an estimated 75\%--85\% of CSN forum participants change their sentiment in a positive direction through online interactions with other community members.
Abstract: Many users join online health communities (OHC) to obtain information and seek social support. Understanding the emotional impacts of participation on patients and their informal caregivers is important for OHC managers. Ethnographical observations, interviews, and questionnaires have reported benefits from online health communities, but these approaches are too costly to adopt for large-scale analyses of emotional impacts. A computational approach using machine learning and text mining techniques is demonstrated using data from the American Cancer Society Cancer Survivors Network (CSN), an online forum of nearly a half million posts. This approach automatically estimates the sentiment of forum posts, discovers sentiment change patterns in CSN members, and allows investigation of factors that affect the sentiment change. This first study of sentiment benefits and dynamics in a large-scale health-related electronic community finds that an estimated 75\%--85\% of CSN forum participants change their sentiment in a positive direction through online interactions with other community members. Two new features, \textit{Name} and \textit{Slang}, not previously used in sentiment analysis, facilitate identifying positive sentiment in posts. This work establishes foundational concepts for further studies of sentiment impact of OHC participation and provides insight useful for the design of new OHC's or enhancement of existing OHCs in providing better emotional support to their members.
101 citations
••
TL;DR: The ACS‐NPCDP is a multimodality, multicenter study of the feasibility of early prostate cancer detection using digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA).
Abstract: BACKGROUND: Few data are available to describe the clinical and pathologic characteristics of prostate cancers detected through early detection programs. The American Cancer Society National Prostate Cancer Detection Project (ACS-NPCDP) is a multimodality, multicenter study of the feasibility of early prostate cancer detection using digital rectal examination (DRE), transrectal ultrasound (TRUS), and prostate specific antigen (PSA). One hundred fifty-six prostate cancers are available from this project for analysis. METHODS: The ACS-NPCDP is a prospective, comparative study of a cohort of 2,999 men between 55 and 70 years of age not suspected of having prostate cancer. DRE, TRUS, and PSA are performed for each subject on an annual basis for as long as 5 years. Biopsies are performed on the basis of recommendations from DRE or TRUS results. Although elevated PSA alone was not typically a basis for biopsy, in some instances biopsies were recommended because of the degree of elevation in PSA. Diagnoses are confirmed by participating pathologists and by pathologic analysis. RESULTS: A small proportion of cancers detected were advanced in terms of the clinical stage at time of diagnosis. A total of only six cancers were stage C1 to D1, and five of these were preexisting cancers detected at the first examination. Cancers detected by DRE tended to be more advanced than those found on the basis of only TRUS or PSA. A large proportion of patients received curative therapy, involving radical prostatectomy for 67.9% and radiation therapy for 17.9%. Of 100 men presumed to have organ confined disease and treated by prostatectomy, 64 actually proved to have localized cancer, a rate of upstaging of 36.0%. PSA level and PSA density were associated with the detection of organ confined cancer, but several advanced cancers had PSA levels in the normal range, limiting the usefulness of these measures for staging. CONCLUSIONS: The cancers resulting from this multimodality detection effort represented a spectrum of pathologic findings. These data, however, suggest that early detection interventions in men not suspected to have prostate cancer will yield tumors with a favorable stage distribution that are likely to benefit from treatment. Further follow-up evaluation is needed to determine whether these benefits are reflected in long-term mortality and survival experience.
101 citations
••
SRI International1, Stanford University2, Brown University3, Northwestern University4, University of Southern California5, Indiana University6, University of California, San Francisco7, Wake Forest University8, Memorial Sloan Kettering Cancer Center9, University of Washington10, National Institutes of Health11, California Pacific Medical Center12, Washington University in St. Louis13, Roswell Park Cancer Institute14, University of Alabama15, Rutgers University16, Johns Hopkins University17, City of Hope National Medical Center18, Vanderbilt University19, Medical College of Wisconsin20, Jackson State University21, American Cancer Society22, University of Texas Health Science Center at Houston23, University of North Carolina at Chapel Hill24, University of Miami25, University of Utah26, Cancer Prevention Institute of California27, University of Illinois at Chicago28, Fred Hutchinson Cancer Research Center29, University of Hawaii at Manoa30, Henry Ford Health System31, Group Health Cooperative32, Harvard University33, University of Texas MD Anderson Cancer Center34, Cedars-Sinai Medical Center35
TL;DR: The first genome-wide association study meta-analysis of smoking behavior in African Americans in the Study of Tobacco in Minority Populations Genetics Consortium is reported, which finds the contribution of genetic variation to disparities in cigarette consumption, SC and smoking-attributable disease between African Americans and European Americans.
Abstract: The identification and exploration of genetic loci that influence smoking behaviors have been conducted primarily in populations of the European ancestry. Here we report results of the first genome-wide association study meta-analysis of smoking behavior in African Americans in the Study of Tobacco in Minority Populations Genetics Consortium (n = 32,389). We identified one non-coding single-nucleotide polymorphism (SNP; rs2036527[A]) on chromosome 15q25.1 associated with smoking quantity (cigarettes per day), which exceeded genome-wide significance (β = 0.040, s.e. = 0.007, P = 1.84 × 10(-8)). This variant is present in the 5'-distal enhancer region of the CHRNA5 gene and defines the primary index signal reported in studies of the European ancestry. No other SNP reached genome-wide significance for smoking initiation (SI, ever vs never smoking), age of SI, or smoking cessation (SC, former vs current smoking). Informative associations that approached genome-wide significance included three modestly correlated variants, at 15q25.1 within PSMA4, CHRNA5 and CHRNA3 for smoking quantity, which are associated with a second signal previously reported in studies in European ancestry populations, and a signal represented by three SNPs in the SPOCK2 gene on chr10q22.1. The association at 15q25.1 confirms this region as an important susceptibility locus for smoking quantity in men and women of African ancestry. Larger studies will be needed to validate the suggestive loci that did not reach genome-wide significance and further elucidate the contribution of genetic variation to disparities in cigarette consumption, SC and smoking-attributable disease between African Americans and European Americans.
101 citations
Authors
Showing all 1345 results
Name | H-index | Papers | Citations |
---|---|---|---|
Walter C. Willett | 334 | 2399 | 413322 |
Meir J. Stampfer | 277 | 1414 | 283776 |
Frank B. Hu | 250 | 1675 | 253464 |
David J. Hunter | 213 | 1836 | 207050 |
Edward Giovannucci | 206 | 1671 | 179875 |
Irving L. Weissman | 201 | 1141 | 172504 |
Bernard Rosner | 190 | 1162 | 147661 |
Susan E. Hankinson | 151 | 789 | 88297 |
Paolo Boffetta | 148 | 1455 | 93876 |
Jeffrey A. Bluestone | 143 | 515 | 77080 |
Richard D. Smith | 140 | 1180 | 79758 |
Garth D. Illingworth | 137 | 505 | 61793 |
Brian E. Henderson | 137 | 712 | 69921 |
Ahmedin Jemal | 132 | 500 | 380474 |
Michael J. Thun | 129 | 392 | 79051 |